iPCI 2023

Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

Dr van Soest is an experimental physicist by training (MSc Rijksuniversiteit Groningen 1997). In 2005 he joined the Biomedical Engineering group of the Thorax Center at Erasmus University Medical Center, Rotterdam, NL. Starting a new research topic in optical imaging and taking on the existing research in intravascular ultrasound, he developed his own research line. He became a member of the faculty in 2010 and was appointed Associate Professor in 2015.

He leads the research group “Invasive imaging”, which investigates catheter-based imaging technologies, primarily aimed at guidance of cardiovascular interventions but with an eye to other applications as well. 

Dr Hector Garcia-Garcia is director of angiographic, intravascular ultrasound, optical coherence tomography and near infrared spectroscopy imaging at the Cardiovascular Core Laboratory, MedStar Cardiovascular Research Network, MedStar Washington Hospital Center (MWHC). He is also chairman of the Clinical Event committee and an attending cardiologist at MedStar Heart and Vascular Institute, MWHC.

Prior to joining MedStar, he served as director of the core invasive imaging laboratory at a clinical research organisation and as a researcher at the Erasmus Medical Center, Rotterdam. He obtained his degree from the Universidad Autónoma de Guadalajara, Mexico. He completed a residency in cardiology and a fellowship in interventional cardiology at the Instituto Nacional de Cardiologia Ignacio Chavez and the Universidad Nacional Autónoma de Mexico. His master’s degree in epidemiology and his doctorate degree in clinical research are from the Erasmus University Rotterdam, the…

Dr Richard Shlofmitz is the chairman of the department of cardiology a St. Francis Hospital the Heart Center, USA, and has been with St. Francis Hospital since 1987. He has served as principal investigator in numerous percutaneous interventional trials at St. Francis Hospital.

He received his medical degree from New York University Grossman School of Medicine and has been in practice for over 20 years.
 

Dr Giulio Guagliumi is an Interventional Cardiologist at Galeazzi Sant'Ambrogio, Milano, IT. He is an internationally recognised leader in the use of Optical Coherence Tomography (OCT) in the coronary arteries.

Dr Guagliumi's research interests combines scientific and medical training, expertise in conducting prospective, randomised trials, and leadership in the field of high-resolution imaging applied to evaluation of in-vivo stent vascular responses. 

Prof David Erlinge is Head of the Cardiology Department at Skane University Hospital, Lund, SE. He graduated in medicine from the University of Lund, in 1990, where he also earned his Ph.D.

In 2006 he received the Lars Werkö distinguished research fellowship and was appointed Professor in Cardiology at Lund University in 2008.

Prof Erlinge’s clinical specialty is invasive cardiology (PCI) and his main research interests include acute coronary syndromes, platelet function, and cardioprotection. 

Dr Alexander Hirsch is an Assistant Professor and Principal Investigator of Cardiovascular Imaging (MRI) at Erasmus University Medical Center, Rotterdam, NL.

He trained as a cardiologist at the Academic Medical Center in Amsterdam and registered as a cardiologist in 2013. He joined the department of Cardiology and Radiology of the Erasmus MC in November 2016 and his main focus is CMR.

His main research interests are CMR in ischaemic and non-ischaemic cardiomyopathy and the application of novel imaging techniques like T1-mapping and 4D flow.